AIM: Early gastric cancer (EGC) may have a 5-year survival rate of over 90% following surgery. Early multifocal gastric cancer (EMGC) accounts for between 8.3 and 17% of all EGCs. A multicenter retrospective study is reported of prevalence, characteristics, prognosis and type of resection for EMGC patients. METHOD: 333 patients with EGC were operated on, between January 1979 and December 1988, and followed to June 1996. RESULTS: 33 EGC patients had EMGC. There was no significant difference in clinico-pathological features between EGC and EMGC. 21 cases of EMGC underwent a subtotal gastrectomy and 12 underwent a total gastrectomy. Recurrences after subtotal gastrectomy were, respectively, 10 and 18% for EGC and EMGC patients (p=0.2). The cumulative 5 years specific survival rate for 298 EGC and 34 EMGC were 94 and 90%, respectively (p=0.9). Five-year survival rates after subtotal gastrectomy were 92 and 90% for EGC and EMGC patients, respectively (p=0.8). CONCLUSION: EGC and EMGC had the same clinico-pathological features and prognosis. A careful follow up of the stomach remnant is essential.
AIM: Early gastric cancer (EGC) may have a 5-year survival rate of over 90% following surgery. Early multifocal gastric cancer (EMGC) accounts for between 8.3 and 17% of all EGCs. A multicenter retrospective study is reported of prevalence, characteristics, prognosis and type of resection for EMGC patients. METHOD: 333 patients with EGC were operated on, between January 1979 and December 1988, and followed to June 1996. RESULTS: 33 EGCpatients had EMGC. There was no significant difference in clinico-pathological features between EGC and EMGC. 21 cases of EMGC underwent a subtotal gastrectomy and 12 underwent a total gastrectomy. Recurrences after subtotal gastrectomy were, respectively, 10 and 18% for EGC and EMGC patients (p=0.2). The cumulative 5 years specific survival rate for 298 EGC and 34 EMGC were 94 and 90%, respectively (p=0.9). Five-year survival rates after subtotal gastrectomy were 92 and 90% for EGC and EMGC patients, respectively (p=0.8). CONCLUSION:EGC and EMGC had the same clinico-pathological features and prognosis. A careful follow up of the stomach remnant is essential.
Authors: Hyeonjin Seong; Jin Il Kim; Hyun Jeong Lee; Hyun Jin Kim; Hyung Joon Cho; Hye Kang Kim; Dae Young Cheung; Dong Jin Kim; Wook Kim; Tae-Jung Kim Journal: World J Gastroenterol Date: 2013-11-28 Impact factor: 5.742
Authors: Ji Young Choi; Young Soo Park; Hwoon-Yong Jung; Da Hye Son; Ji Yong Ahn; Seungbong Han; Hyun Lim; Kwi-Sook Choi; Jeong Hoon Lee; Do Hoon Kim; Kee Don Choi; Ho June Song; Gin Hyug Lee; Jin-Ho Kim Journal: Surg Endosc Date: 2014-09-24 Impact factor: 4.584
Authors: D Serban; C Branescu; C Savlovschi; G Simion; A Mihai; A El-Khatib; C Tudor; A Nica; G Vancea; M Ghelase; A M Dascalu Journal: J Med Life Date: 2016 Jul-Sep
Authors: Sung Jae Park; Young Soo Park; In Sub Jung; Hyuk Yoon; Cheol Min Shin; Sang-Hoon Ahn; Do Joong Park; Hyung Ho Kim; Nayoung Kim; Dong Ho Lee Journal: PLoS One Date: 2018-06-01 Impact factor: 3.240